Malignant tumor of colon
|
0.100 |
Biomarker
|
disease |
BEFREE |
Our data identify the MDSC-IL-10-STAT3-DNMT3b-IRF8 pathway as a link between chronic inflammation and colon cancer initiation.
|
30540937 |
2018 |
Malignant tumor of colon
|
0.100 |
PosttranslationalModification
|
disease |
BEFREE |
Importantly, by relieving the repression on DNMT3b, the lower expression of miR-203 in CRC caused ABCG2 promoter methylation and remarkable lower ABCG2 expression in colon cancer cell lines and the patient CRC specimens.
|
27253631 |
2017 |
Malignant tumor of colon
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Furthermore, transduction of miR-339 and miR-766 expressing viruses into colon cancer cell lines (SW480 and HCT116) decreased DNMT3B expression (1.5, 3-fold) and (3, 4-fold), respectively.
|
27668319 |
2016 |
Malignant tumor of colon
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Our results suggest that DNMT3b polymorphism is involved in the development of colon cancer and non-random genes promoter methylation among Iranian population.
|
25769449 |
2015 |
Malignant tumor of colon
|
0.100 |
Biomarker
|
disease |
BEFREE |
Our results confirm that depletion of DNMT3B specifically reduced the proliferation rate of DNMT3B-overexpressing colon cancer cell lines.
|
22563479 |
2012 |
Malignant tumor of colon
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Our results show a new molecular mechanism of aberrant DNMT3B regulation in colon cancer and suggest that its expression is associated with the methylation of constitutively hypermethylated promoters in the healthy colon.
|
22244828 |
2012 |
Malignant tumor of colon
|
0.100 |
Biomarker
|
disease |
BEFREE |
The purpose of this study was to identify the targets of DNMT3B, an essential DNA methyltransferase in mammals, in colon cancer.
|
20454457 |
2010 |
Malignant tumor of colon
|
0.100 |
Biomarker
|
disease |
BEFREE |
We screened genome wide for novel methylated genes through methylation subtraction of a genetic demethylation model of colon cancer (double knockout of DNMT1 and DNMT3B in HCT116) and identified DLEC1 (Deleted in lung and oesophageal cancer 1), a major 3p22.3 TSG, as one of the methylated targets.
|
19156137 |
2009 |
Malignant tumor of colon
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
We hypothesized that cellular DNMT3B level might influence the occurrence of widespread CpG island methylation (i.e., the CpG island methylator phenotype, CIMP) in colon cancer.
|
19470733 |
2009 |
Malignant tumor of colon
|
0.100 |
PosttranslationalModification
|
disease |
BEFREE |
We chose 44 genes coregulated by DNMT3B and PRC1/PRC2 to test whether these criteria would accurately identify novel targets of epigenetic silencing in colon cancer.
|
19723660 |
2009 |
Malignant tumor of colon
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
DNMT3b SNP has been associated with susceptibility to lung, head, neck, and breast cancer, but its association with the development of colon cancer has not been reported.
|
17318376 |
2007 |
Malignant tumor of colon
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Comparing miRNA expression profiles between colon cancer cell line HCT 116 and its derivative, DNA methyltransferase 1 and 3b (DNMT1 and DNMT3b) double knockout cell line, we found that the expression of about 10% miRNAs was regulated by DNA methylation.
|
17660710 |
2007 |